This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Xplore Reports Q2’12 Results & Growth In Q2 Revenue

Xplore Technologies Corp. (OTCQB: XLRT) (“Xplore” or the “Company”), a manufacturer of award-winning rugged tablet PCs, today reported results for the second quarter of fiscal 2012. Revenue for the three and six months ended September 30, 2011 was $5,100,000 and $7,778,000, respectively, as compared to $4,328,000 and $9,406,000 for the three and six months ended September 30, 2010, respectively. The increase in revenue of approximately 18% for the three months ended September 30, 2011 as compared to the three months ended September 30, 2010 and the decrease in revenue of approximately 17% for the six months ended September 30, 2011 as compared to September 30, 2010 were attributable to the Company’s current transition to its new product line, the iX104C5, which was introduced near the end of the first fiscal quarter of fiscal 2012. The Company believes that the six month revenue comparison is skewed by the Company’s decreased revenue caused by the aforementioned transition in the first quarter of fiscal 2012, while the three month revenue comparison provides evidence of the iX104C5’s traction with customers and of the transition effects subsiding.

“We are pleased with the increase in revenue for our second quarter of approximately 90% over our first quarter and of approximately 18% over the same quarter in the prior year, and believe it positively reflects an initial favorable acceptance of our new C5 in the markets we serve,” said Mark Holleran, President and Chief Operating Officer of Xplore. “Our C5 selling efforts only commenced late in our first fiscal quarter and our markets tend to have a long sales cycle. We believe the second quarter C5 revenue ramp should continue and we expect growth in revenue from the C5 product launch in our remaining quarters of fiscal 2012 ending December 2011 and March 2012. We believe the year to date revenue decline reflects the previously reported delay in the launch of our iX104C5 product family and the market desire to wait for our new and improved line of products.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,790.19 +13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASDAQ 4,748.3610 -32.9030 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs